Across the Pharmaceutical Industry worldwide there is a variety of understanding of SEND and approaches to SEND implementation. Generally, the larger companies have had the resources to follow SEND through its first announcement to the issuance of the SEND Guidance document which set the due dates for SEND to be used for submission of the studies started on or after the due date.
This project creates an electronic survey sponsored by PHUSE, with up to 15 multiple choice questions and an option to provide additional free text information. The survey is sent out to PHUSE members, requesting a 30 day response time, then the responses are compiled, distributed and made publicly available.
Project Leads
Bob Friedman
bfriedman@xybion.com
Lou Ann Kramer
lkramer@cdisc.org
Janice M Fiori
fiori_janice_m@lilly.com
Key Milestones
Project Scope |
Execute an annual survey process to objectively collect data that enables detection of impactful issues and trends (both good and bad) that can be acted upon by the PHUSE community The survey will: Results of the survey will be presented at the PHUSE/FDA CSS. |
Project Leads | |
---|---|
Vanessa Chavez, Labcorp | |
Lindsy Eickhoff, Inotivco | leickhoff@inotivco.com |
Alex Pearce, PHUSE Project Assistant |
|
---|
| ||
---|---|---|
|
Objectives & Deliverables | Timelines |
---|---|
Launch Survey | Q2 2023 |
Present survey results in a poster at PHUSE/FDA CSS |
2023 | Q3 2023 |
Published Deliverables | ||||
---|---|---|---|---|
2016 SEND Survey Results | ||||
2017 SEND Survey Results | ||||
2019 SEND Survey Results presented at the CSS 2016 event | 2016 SEND Survey Results presented at the CSS 2017 event | 2017 SEND Survey Results presented at the CSS 2018 event | 2018 SEND Survey Results presented at the CSS 2019 event | 2019 SEND Survey Results presented at the CSS 2020 event|
2020 SEND Survey Results | ||||
2021 SEND Survey Results | ||||